Investment
Features
FeesSafety
Academy
More
Pluang+

Truist Financial to report Q3 2026 earnings on Oct 16 with live call for investors.

Company Fundamentals
18 Sep 2026
PRNewsWire
View Source
Neutral
Truist Financial to report Q3 2026 earnings on Oct 16 with live call for investors.

Truist Financial Corporation will announce its third quarter 2026 financial results before the market opens on October 16, 2026. CEO Mike Lyons and CFO Mike Maguire will host a conference call at 8 a.m. ET to discuss the results. Investors can join the call via webcast or phone, with replay available for 30 days. Truist is a major U.S. bank with $556 billion in assets as of mid-2026, offering a wide range of financial services.

Truist Financial Corporation's upcoming third quarter 2026 earnings call is scheduled for October 16, 2026. For readers following the Financials sector, here is Pluang's market snapshot as of Sep 18, 2026 19:02 WIB: out of 81 priced US Financials stocks, 27 rose and 48 fell. HSBC traded at USD 101.70 with a 1-day change of -1.11%, Riot Platforms at USD 22.11 with +1.05%, and Hut 8 at USD 91.90 with +1.00%.

More News

Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals halted new patient enrollment in its psychiatry clinical trials for the drug azetukalner after reports of neuropsychiatric side effects. This pause led to a sharp 27.6% drop in its stock price, marking its worst day since 2017. ...

Market News
Bearish
47 minutes ago
Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma reported an EPS of -$0.24, beating analyst estimates of -$0.29, and revenue of $6.5 million, slightly above expectations. The company secured a strategic partnership with Sobi for its drug lacutamab, receiving a $75 million upfront paym...

Company Fundamentals
Bullish
1 hour ago
Paychex to report Q1 2027 earnings with expected EPS of $1.32 and $1.63B revenue on Sept 23

Paychex to report Q1 2027 earnings with expected EPS of $1.32 and $1.63B revenue on Sept 23

Paychex, a provider of human capital management solutions, will release its Q1 fiscal 2027 earnings on September 23, 2026. Analysts expect earnings per share (EPS) of $1.32, up from $1.22 last year, and revenue of about $1.63 billion, higher than las...

Company Fundamentals
Bullish
2 hours ago
Barclays cuts Lennar price target to $70 amid weak Q3 earnings and housing market challenges

Barclays cuts Lennar price target to $70 amid weak Q3 earnings and housing market challenges

Barclays lowered its price target for Lennar Corporation to $70 from a higher level, citing a 52% drop in Q3 net earnings to $284 million and an 8.6% revenue decline to $8.05 billion. The homebuilder faces headwinds from rising mortgage rates and wea...

Analyst Insights
Bearish
2 hours ago
Guggenheim raises price target for Restaurant Brands International to $86 amid growth and share buybacks

Guggenheim raises price target for Restaurant Brands International to $86 amid growth and share buybacks

Guggenheim has raised its price target for Restaurant Brands International (QSR) to $86 from $85 and reiterated a Buy rating, reflecting confidence in the company's strategic growth. Restaurant Brands International is enhancing shareholder value thro...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App